Dossier Atherosclerosis | Page 2 of 2 | Observatoire de la prévention de l'Institut de Cardiologie de Montréal

A new metabolite derived from the microbiota linked to cardiovascular disease

29 March 2020

|

Researchers have identified a new metabolite derived from the gut microbiota, phenylacetylglutamine, which is associated with cardiovascular disease through a mechanism of hyperactivation of blood platelets.

Exercise reduces cardiovascular inflammation by modulating the immune system

3 January 2020

|

Dr Martin Juneau, M.D., FRCP

Voluntary and regular exercise in mice decreases the number of inflammatory leukocytes (white blood cells) in the bloodstream. The underlying mechanism involves a decrease in the secretion of the hormone leptin by fat cells.

The importance of maintaining normal cholesterol levels, even at a young age

30 December 2019

|

Dr Martin Juneau, M.D., FRCP

One study reports that young adults with high blood cholesterol levels are much more likely to be affected by cardiovascular disease later in life.

Eggs: To consume with moderation

2 September 2019

|

Dr Martin Juneau, M.D., FRCP

A recent study found a significant, albeit modest, association between the consumption of eggs or dietary cholesterol and the incidence of cardiovascular disease and all-cause mortality.